Dr. Andre Reed, MD

NPI: 1003885393
Total Payments
$1,317
2024 Payments
$183.45
Companies
15
Transactions
42
Medicare Patients
1,398
Medicare Billing
$254,279

Payment Breakdown by Category

Food & Beverage$738.48 (56.1%)
Gifts$579.00 (43.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $738.48 41 56.1%
Gift $579.00 1 43.9%

Top Paying Companies

Company Total Records Latest Year
Allergan Inc. $579.00 1 $0 (2017)
Takeda Pharmaceuticals U.S.A., Inc. $187.25 20 $0 (2021)
Ethicon US, LLC $167.03 5 $0 (2022)
Phathom Pharmaceuticals, Inc. $153.42 3 $0 (2024)
Davol Inc. $30.03 1 $0 (2024)
Bard Peripheral Vascular, Inc. $29.22 1 $0 (2023)
Takeda Pharmaceuticals America, Inc. $28.79 3 $0 (2017)
Kowa Pharmaceuticals America, Inc. $25.46 1 $0 (2022)
Intuitive Surgical, Inc. $24.59 1 $0 (2019)
Innocoll Incorporated $22.17 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $183.45 4 Phathom Pharmaceuticals, Inc. ($153.42)
2023 $29.22 1 Bard Peripheral Vascular, Inc. ($29.22)
2022 $68.65 3 Ethicon US, LLC ($27.26)
2021 $64.61 3 Takeda Pharmaceuticals U.S.A., Inc. ($42.44)
2019 $127.60 11 Takeda Pharmaceuticals U.S.A., Inc. ($44.68)
2018 $198.78 13 Takeda Pharmaceuticals U.S.A., Inc. ($100.13)
2017 $645.17 7 Allergan Inc. ($579.00)

All Payment Transactions

42 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/07/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $15.03 General
Category: GASTROENTEROLOGY
08/07/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $123.06 General
Category: GASTROENTEROLOGY
08/01/2024 Davol Inc. Phasix Mesh (Device) Food and Beverage In-kind items and services $30.03 General
Category: Surgery
07/11/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $15.33 General
Category: GASTROENTEROLOGY
06/06/2023 Bard Peripheral Vascular, Inc. BARD MARQUEE (Device) Food and Beverage In-kind items and services $29.22 General
Category: Vascular/Oncology
11/21/2022 Kowa Pharmaceuticals America, Inc. Seglentis (Drug) Food and Beverage Cash or cash equivalent $25.46 General
Category: Pain Management
08/24/2022 Ethicon US, LLC Megadyne (Device), Harmonic Food and Beverage In-kind items and services $27.26 General
Category: Energy
04/14/2022 Lucid Diagnostics Inc. Food and Beverage In-kind items and services $15.93 General
10/15/2021 Innocoll Incorporated XARACOLL (Drug) Food and Beverage In-kind items and services $22.17 General
Category: PAIN
07/21/2021 Takeda Pharmaceuticals U.S.A., Inc. GATTEX (Drug) Food and Beverage In-kind items and services $21.34 General
Category: INTERNAL MEDICINE
06/24/2021 Takeda Pharmaceuticals U.S.A., Inc. GATTEX (Drug) Food and Beverage In-kind items and services $21.10 General
Category: INTERNAL MEDICINE
12/14/2019 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $24.59 General
Category: SURGERY
09/12/2019 Ethicon US, LLC LINX Reflux Management System (Device) Food and Beverage In-kind items and services $26.41 General
Category: Endo-Mechanical
08/15/2019 Takeda Pharmaceuticals U.S.A., Inc. Dexilant (Drug) Food and Beverage In-kind items and services $3.00 General
Category: Upper GI
06/13/2019 Takeda Pharmaceuticals U.S.A., Inc. Dexilant (Drug) Food and Beverage In-kind items and services $8.82 General
Category: Upper GI
04/19/2019 Takeda Pharmaceuticals U.S.A., Inc. Dexilant (Drug) Food and Beverage In-kind items and services $4.48 General
Category: Upper GI
03/07/2019 Takeda Pharmaceuticals U.S.A., Inc. Dexilant (Drug) Food and Beverage In-kind items and services $5.74 General
Category: Upper GI
02/28/2019 OptiNose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $12.31 General
Category: Otolaryngology (Ear, Nose, Throat)
02/21/2019 Takeda Pharmaceuticals U.S.A., Inc. Dexilant (Drug) Food and Beverage In-kind items and services $3.89 General
Category: Upper GI
02/08/2019 Takeda Pharmaceuticals U.S.A., Inc. Dexilant (Drug) Food and Beverage In-kind items and services $15.00 General
Category: Upper GI
01/24/2019 Teleflex LLC Access Solutions: Weck brand (Device) Food and Beverage In-kind items and services $19.61 General
Category: Surgical
01/17/2019 Takeda Pharmaceuticals U.S.A., Inc. Dexilant (Drug) Food and Beverage In-kind items and services $3.75 General
Category: Upper GI
12/14/2018 Takeda Pharmaceuticals U.S.A., Inc. Dexilant (Drug) Food and Beverage In-kind items and services $12.20 General
Category: Upper GI
11/15/2018 Takeda Pharmaceuticals U.S.A., Inc. Dexilant (Drug) Food and Beverage In-kind items and services $5.00 General
Category: Upper GI
09/28/2018 Takeda Pharmaceuticals U.S.A., Inc. Dexilant (Drug) Food and Beverage In-kind items and services $22.89 General
Category: Upper GI

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 434 583 $258,965 $78,087
2022 4 367 500 $222,336 $66,746
2021 5 353 481 $210,751 $65,564
2020 4 244 328 $132,573 $43,882
Total Patients
1,398
Total Services
1,892
Medicare Billing
$254,279
Procedure Codes
17

All Medicare Procedures & Services

17 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
31579 Exam to assess movement of vocal cord flaps using an endoscope Office 2023 212 349 $177,470 $53,296 30.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 101 101 $42,451 $12,737 30.0%
70371 Imaging of voice box with speech evaluation Office 2023 76 82 $22,602 $7,235 32.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 45 51 $16,441 $4,819 29.3%
31579 Exam to assess movement of vocal cord flaps using an endoscope Office 2022 193 314 $158,102 $47,269 29.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 86 86 $35,888 $10,512 29.3%
70371 Imaging of voice box with speech evaluation Office 2022 63 72 $19,297 $6,302 32.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 25 28 $9,049 $2,663 29.4%
31579 Examination to assess movement of vocal cord flaps using an endoscope Office 2021 172 287 $140,759 $43,954 31.2%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 77 77 $31,758 $9,935 31.3%
70371 Imaging of voice box with speech evaluation Office 2021 67 75 $20,408 $6,862 33.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 26 30 $9,295 $2,546 27.4%
31571 Injection of vocal cords using an endoscope with operating microscope or telescope Facility 2021 11 12 $8,532 $2,267 26.6%
31579 Examination to assess movement of vocal cord flaps using an endoscope Office 2020 125 193 $91,560 $29,810 32.6%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 48 48 $18,943 $6,408 33.8%
70371 Imaging of voice box with speech evaluation Office 2020 50 64 $16,094 $5,700 35.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 21 23 $5,975 $1,964 32.9%

About Dr. Andre Reed, MD

Dr. Andre Reed, MD is a Otolaryngology healthcare provider based in Englewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003885393.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andre Reed, MD has received a total of $1,317 in payments from pharmaceutical and medical device companies, with $183.45 received in 2024. These payments were reported across 42 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($738.48).

As a Medicare-enrolled provider, Reed has provided services to 1,398 Medicare beneficiaries, totaling 1,892 services with total Medicare billing of $254,279. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.

Practice Information

  • Specialty Otolaryngology
  • Location Englewood, CO
  • Active Since 03/17/2006
  • Last Updated 06/01/2023
  • Taxonomy Code 207Y00000X
  • Entity Type Individual
  • NPI Number 1003885393

Products in Payments

  • BOTOX THERAPEUTIC - HH (Biological) $579.00
  • VOQUEZNA (Drug) $153.42
  • Dexilant (Drug) $153.18
  • LINX Reflux Management System (Device) $125.06
  • GATTEX (Drug) $42.44
  • Phasix Mesh (Device) $30.03
  • BARD MARQUEE (Device) $29.22
  • Megadyne (Device) $27.26
  • Seglentis (Drug) $25.46
  • Da Vinci Surgical System (Device) $24.59
  • XARACOLL (Drug) $22.17
  • Amitiza (Drug) $20.42
  • Access Solutions: Weck brand (Device) $19.61
  • Xhance (Drug) $12.31
  • FLEXITOUCH (Device) $11.74
  • Instruments-ENT (Device) $10.93

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Otolaryngology Doctors in Englewood